Skip to main content
. 2020 Jun 11:1–3. doi: 10.1159/000508062

Table 2.

Clinical practice for CRRT for COVID-19

Parameter Clinical practice
Staff Certified doctor of blood purification in critical care

Certified doctor of infectious disease

Experienced medical engineers

Highly trained ICU nurses

Infection prevention and control All staff who care for patient directly and handle CRRT equipment wear PPE: gloves, N95 mask, gown, cap, and face shield

Patient is in an airborne infection isolation room at ICU, or designated ward

CRRT equipment is placed in the anteroom during priming

Access Temporary double-lumen catheter placed using ultrasound

CRRT modality CRRT for initial treatment

Consider transition to daytime RRT until recovery from AKI or can leave from biocontainment isolation

PMMA or AN69ST membrane for initial hemofilter choice

Replacement solution Self-admixture sodium bicarbonate and sodium chloride solution (Na+ 140 mEq/L, K+ 2.0 mEq/L, Ca2+ 1.0 mEq/L, Mg2+ 1.0 mEq/L, Cl− 113 mEq/L, CH3COO− 0.5 mEq/L, HCO3− 35 mEq/L, and glucose 100 mg/dL)

CRRT dosing Deliver a total effluent dose of 20 mL/kg per hour


Anticoagulation Nafamostat mesylate 30–40 mg per hour

Effluent disposal Drain patient-contact effluent in the container and add a coagulant before disposal

Wipe outside of the container with alcohol, then treated as hazardous waste, and dispose

ICU, intensive care unit; CRRT, continuous renal replacement therapy; PPE, personal protective equipment; AKI, acute kidney injury; PMMA, polymethyl methacrylate; AS69ST, polyethylenimine-coated polyacrylonitrile.